Hepatic and Portal Vein Transection by Vascular Stapler in Open Living Donor Hepatectomy

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06910852

Enrollment

Registered

2025-04-04

Start date

2021-06-18

Completion date

2021-11-30

Last updated

2025-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatectomy

Brief summary

To enhance donor safety in living donor liver transplantation (LDLT), the use of vascular staplers for the division of the right portal and hepatic veins in patients undergoing right lobe liver donation has been introduced. This study examines the application of vascular staplers in LDLT and assesses the subsequent feasibility and safety outcomes for donors.

Interventions

PROCEDUREVascular stapler

the utilization of vascular staplers for the division of the right portal and hepatic veins in patients undergoing right lobe liver donation for living donor liver transplantation

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Patients undergoing open living donor hepatectomy * Age ≥ 18 years, ≤ 80 years * Written informed consent

Exclusion criteria

* None.

Design outcomes

Primary

Measure	Time frame
Post-operative complications (Clavien-Dindo classification)	From enrollment to the end of treatment at 6 weeks

Countries

Jordan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026